Physician profile
Diana M Emini
NPI 1306049929
$3,863.35
in general payments reported to CMS, 2019-2025
21 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $188 · 2021: $941 · 2022: $162 · 2023: $418 · 2024: $35.66 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,058 · Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,058.46 |
| Food and Beverage | $996.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,873.55 | 2021-2025 | |
| Stryker Corporation | $639.87 | 2019-2025 | Citrefix, Swanson, Ortholoc 2 Lapifuse |
| Sandoz INC. | $407.56 | 2019-2021 | |
| Mimedx Group, INC. | $153.84 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $144.14 | 2019-2021 | |
| Organogenesis INC. | $72.74 | 2021-2023 | Puraply |
| Sebela Pharmaceuticals INC. | $70.05 | 2019-2022 | |
| Alfasigma USA, INC. | $69.58 | 2020-2022 | |
| Integra Lifesciences Corporation | $65.22 | 2020-2021 | |
| Horizon Therapeutics Plc | $60.86 | 2019-2022 | |
| Paragon 28, INC. | $50.25 | 2023 | Mtp |
| Smith+Nephew, INC. | $48.21 | 2019-2023 | Hat-Trick, Capture |
| Depuy Synthes Sales INC. | $41.05 | 2023 | Tfn-Advance |
| Bioventus LLC | $30.57 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Glenmark Therapeutics INC. | $28.00 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $23.54 | 2021 | |
| Bsn Medical INC | $22.14 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.16 | 2023 | Seglentis |
| Fusion Orthopedics USA, LLC | $15.97 | 2025 | |
| Checkpoint Surgical, INC | $14.71 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Emini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.